Seoyoung found that the combination of metformin treatment and Dipeptidyl peptidase-4 (DPP4) significantly reduced the risk of RA; however, their effect on reducing the risk of RA appeared to be mainly due to DPP4 [55]. Here, DPP4 is linked to rheumatoid arthritis.